Hair Loss Associated with Sertraline: A Case Report
Sertraline is classified as a selective serotonin reuptake inhibitor (SSRI) that is extensively employed in the management of a range of psychiatric conditions, encompassing major depressive disorder and anxiety disorders. While the overall incidence of hair loss is not extensively documented, it i...
Saved in:
Main Authors: | Seyed Hamzeh Hosseini, Hamed Ghazvini, Seyedeh Masoumeh Seyedhosseini Tamijani, Raheleh Rafaiee |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2024-12-01
|
Series: | Case Reports in Clinical Practice |
Subjects: | |
Online Access: | https://crcp.tums.ac.ir/index.php/crcp/article/view/997 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the Effect of Sertraline and Escitalopram on the Treatment of Major Depressive Disorder in Hemodialysis Patients: A Randomized Controlled Trial
by: Tahereh Sabaghian, et al.
Published: (2024-09-01) -
Premature Constriction of Fetal Ductus Arteriosus Caused by Sertraline in a Pregnant Woman: A Case Report
by: Alireza Golbabaei, et al.
Published: (2025-01-01) -
Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
by: Eman Hamed El Morsy, et al.
Published: (2025-01-01) -
Cosmetic filler-induced hair loss: case series and literature review
by: Yutong Xie, et al.
Published: (2024-12-01) -
Caffeine as an Active Molecule in Cosmetic Products for Hair Loss: Its Mechanisms of Action in the Context of Hair Physiology and Pathology
by: Ewelina Szendzielorz, et al.
Published: (2025-01-01)